Position in NSPR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$6,366,361
-$585,861 QoQ
Shares Held
3,905,743
0.0% QoQ
Ownership
8.34%
of shares outstanding
% of Portfolio
2.60%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NSPR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Rosalind Advisors, Inc. holds $44,960,929 across 4 Medical Devices names. NSPR ranks #2 (14.2% of the industry book) .
All Filings in NSPR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,366,361 | 3,905,743 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,952,222 | 3,905,743 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $9,412,840 | 3,905,743 | Shares | Sole | 2025-11-13 | |
| 2025-08-01 | $29,555,309 | 10,987,104 | Shares | Sole | 2025-08-11 | |
| 2025-06-30 | $5,196,254 | 2,289,099 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,119,723 | 2,274,990 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,563,909 | 2,495,783 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,737,643 | 2,514,046 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $6,284,102 | 2,513,641 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,625,966 | 686,062 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,599,795 | 925,194 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||